Tradestie Institutional Equity Comparison Engine
RXD vs SCC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RXD Overall Edge
RXD Captures Institutional Edge (2โ0 Pillars ยท 3โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ProShares UltraShort Health Care (RXD) driven by superior Momentum & Technical, Options & Structure. Fundamentally, RXD trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SCC at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, RXD sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against SCC sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
RXD N/M vs SCC N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
RXD
1Y +26.9% vs -9.0% ยท 52W Pos 29% vs 20%
Options & Structure Winner
RXD
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (100th %ile IV)
RXD
NYSE Arca
ProShares UltraShort Health Care
Institutional Equity
$11.95
+1.01% 1D
Market Cap
N/A
1M Return
-11.84%
1Y Return
+26.9%
Forward P/E
N/M
Unified AI Score
58.1 / 100
HOLD
Tech 80.0
Fund 66.0
Flow 50.0
Mom 68.9
SCC
NYSE Arca
ProShares UltraShort Consumer Discretionary
Institutional Equity
$14.00
+3.03% 1D
Market Cap
N/A
1M Return
-10.22%
1Y Return
-8.97%
Forward P/E
N/M
Unified AI Score
56.5 / 100
HOLD
Tech 71.0
Fund 63.0
Flow 50.0
Mom 68.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RXD +26.9%
SCC -8.97%
Spread: +35.87 pp (RXD Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RXD TTM Op. Margin: N/A
SCC TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RXD vs SCC. Trailing 12-month operating profitability (RXD N/A vs SCC N/A) and valuation multiples (RXD N/M vs SCC N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RXD | SCC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 29% ($8โ$21) | 20% ($13โ$18) | Stronger Trend | RXD |
| Beta / 30D Volatility Risk Regime | -0.21ฮฒ ยท 40% Vol | -2.18ฮฒ ยท 54% Vol | Lower Realized Risk | RXD |
| Unified Institutional Score Composite Signal | 58.1 / 100 (HOLD) | 56.5 / 100 (HOLD) | Higher Composite | RXD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RXD vs SCC Buy Guide
RXD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
SCC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RXD nor SCC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.